Vietnam MOH registration 2402954ĐKLH/BYT-HTTB
Qualitative Test for Abnormal Blood Group Antibodies
VN: Thuốc thử xét nghiệm định tính kháng thể nhóm máu bất thường
Vietnam·Risk Class TTBYT Loại C·Set DAYcells I-II-III·Haemokinesis Limited·Registered Oct 24, 2024Registration details
- Analysis ID
- 2402954ĐKLH/BYT-HTTB
- Submission ID
- 000.00.04.G18-230629-0002
- Product Type
- Set DAYcells I-II-III
- Product Code
- 60123-3
Company information
- Manufacturer
- Haemokinesis Limited
- Manufacturer Country
- AUSTRALIA
- Product Owner
- Haemokinesis Limited
- Authorized Representative
- CÔNG TY CỔ PHẦN THIẾT BỊ Y TẾ VIMEC
Technical details
- Intended Use
- In-vitro diagnostic products are permitted to be used only by qualified personnel. These products are intended to detect the presence or absence of abnormal blood group antibodies in the patient's blood and/or the blood donor sample.
Dates and status
- Registration Date
- Oct 24, 2024
About this record
Access comprehensive regulatory information for Qualitative Test for Abnormal Blood Group Antibodies in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402954ĐKLH/BYT-HTTB and manufactured by Haemokinesis Limited. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN THIẾT BỊ Y TẾ VIMEC.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI300,000+ Devices